ABC
La bronchiolite acuta del lattante
FRANCO PANIZON1, ANTONIO PULELLA2, ROCCO CAVALIERE2, ANGELA TISCI2
1Professore Emerito, Dipartimento di Scienze della Riproduzione e dello Sviluppo, Università di Trieste
2UO di Pediatria, Ospedale di Portogruaro
Marzo 2007 - pagg. 177 -180
Parole chiave
IT
Bronchiolite
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Goodman D. Bronchiolitis. In: Behrman RE,
Kliegman RM, Jenson HB (eds). Nelson Textbook
of Pediatrics. 17° ed. Philadelphia: WB
Saunders, 2004:1415-7.
2. Boat TF. Cystic fibrosis. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17° ed. Philadelphia: WB Saunders, 2004:1437-50.
3. Boas S. Bronchiolitis obliterans. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17° ed. Philadelphia: WB Saunders, 2004:1422.
4. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161: 158-64.
5. Hardy KA, Schidlow DV, Zaeri N. Obliterative bronchiolitis in children. Chest 1988; 93:460-6.
6. Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2000;29:341- 50.
7. Denny FW, Collier AM, Henderson FW, Clyde WA Jr. The epidemiology of bronchiolitis. Pediatr Res 1977;11:234-6.
8. Panitch HB. Bronchiolitis in infants. Curr Opin Pediatr 2001;13: 256-60.
9. Pierangeli A, Gentile M, Di Marco P, et al. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J Med Virol 2007;79:463-8.
10. McIntosh K. Respiratory Syncytial Virus. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17° ed. Philadelphia: WB Saunders, 2004:1076-9.
11. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350: 443-50.
12. Welliver RC. Immunology of respiratory syncytial virus infection: eosinophils, cytokines, chemokines and asthma. Pediatr Infect Dis J 2000;19:780-3.
13. Emboriadou M, Hatzistilianou M, Magnisali Ch, et al. Human neutrophil elastase in RSV bronchiolitis. Ann Clin Lab Sci 2007; 37:79-84.
14. Elliott MB, Welliver RC Sr, Laughlin TS, et al. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol 2007; 79:447-56.
15. Skelton R, Holland P, Darowski M. Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr 1999;88: 942-6.
16. Bertrand P, Aranibar H, Castro E, Sanchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatric Pulmonol 2001;31: 284-8.
17. Wainwright C Altamirano L, Cheney M, et al. A multicenter, randomized, doubleblind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003;349:27-33.
18. Patel H, Platt RW, Pekeless GS, Ducharme FM. A randomized controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr 2002;141:818-24.
19. Abul-Ainine A, Luyt D. Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Arch Dis Child 2002;86:276- 9.
20. Patel H, Gouin S, Platt RW. Randomised double-blind, placebo controlled trial of oral albuterol in infants with mild-to moderate acute viral bronchiolitis. J Pediatr 2003;142: 509-14.
21. Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104:e77.
22. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 2000;105(4):e44.
23. Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection- induced lower airway disease: a randomized, placebo-conrolled trial. J Pediatr 2003;143:725-30.
24. Schuh S, Coates AL, Binnic R. Efficacy of oral dexametasone in outpatients with acute bronchiolitis. J Pediatr 2002;140:27.
25. McBride JT. Dexametasone and bronchiolitis: a new look at an old therapy? J Pediatr 2002;140:8-12.
26. Cade A, Brownhee KG, Conway SP. Randomized placebo controled trial of nebulized corticosteroids in acute syncitial viral bronchiolitis. Arch Dis Child 2000;82:126.
27. Grenville F, Foxeverard ML, Marsh MJ, Millner AD. Randomized controled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child 1999;80:343.
28. Blom D, Emers M, Bont L, van Aalderen W, van Woensel J. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007;24:CD004881.
29. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Arch Pediatr Adolesc Med 1996;150:1166-72.
30. Spurling G, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2007;(1):CD 005189.
31. Wohl ME, Chernick V. Treatment of acute bronchiolitis. N Engl J Med 2003;349:82-3.
32. Breese Hall CC. Managing bronchiolitis and respiratory syncytial virus. Acta Paediatr Adolesc Med 2004;158:111.
33. Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis. A systematic review. Arch Pediatr Adolesc Med 2004;158:119-26.
34. van Woensel JB, van Aalderen WM. Treatment of bronchiolitis: the story continues. Lancet 2002;360:101-2.
35. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 1999;104:1334-41.
36. King WJ, Le Saux N, Sampson M, Gaboury I, Norris M, Moher D. Effect of point of care information on impatient management of bronchiolitis. BMC Pediatr 2007;7:4.
37. Hammerschlag MR. Clamidial infections. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Paediatrics. 17° ed. Philadelphia: WB Saunders, 2004:994-9.
2. Boat TF. Cystic fibrosis. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17° ed. Philadelphia: WB Saunders, 2004:1437-50.
3. Boas S. Bronchiolitis obliterans. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17° ed. Philadelphia: WB Saunders, 2004:1422.
4. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161: 158-64.
5. Hardy KA, Schidlow DV, Zaeri N. Obliterative bronchiolitis in children. Chest 1988; 93:460-6.
6. Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2000;29:341- 50.
7. Denny FW, Collier AM, Henderson FW, Clyde WA Jr. The epidemiology of bronchiolitis. Pediatr Res 1977;11:234-6.
8. Panitch HB. Bronchiolitis in infants. Curr Opin Pediatr 2001;13: 256-60.
9. Pierangeli A, Gentile M, Di Marco P, et al. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J Med Virol 2007;79:463-8.
10. McIntosh K. Respiratory Syncytial Virus. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17° ed. Philadelphia: WB Saunders, 2004:1076-9.
11. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350: 443-50.
12. Welliver RC. Immunology of respiratory syncytial virus infection: eosinophils, cytokines, chemokines and asthma. Pediatr Infect Dis J 2000;19:780-3.
13. Emboriadou M, Hatzistilianou M, Magnisali Ch, et al. Human neutrophil elastase in RSV bronchiolitis. Ann Clin Lab Sci 2007; 37:79-84.
14. Elliott MB, Welliver RC Sr, Laughlin TS, et al. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol 2007; 79:447-56.
15. Skelton R, Holland P, Darowski M. Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr 1999;88: 942-6.
16. Bertrand P, Aranibar H, Castro E, Sanchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatric Pulmonol 2001;31: 284-8.
17. Wainwright C Altamirano L, Cheney M, et al. A multicenter, randomized, doubleblind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003;349:27-33.
18. Patel H, Platt RW, Pekeless GS, Ducharme FM. A randomized controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr 2002;141:818-24.
19. Abul-Ainine A, Luyt D. Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Arch Dis Child 2002;86:276- 9.
20. Patel H, Gouin S, Platt RW. Randomised double-blind, placebo controlled trial of oral albuterol in infants with mild-to moderate acute viral bronchiolitis. J Pediatr 2003;142: 509-14.
21. Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104:e77.
22. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 2000;105(4):e44.
23. Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection- induced lower airway disease: a randomized, placebo-conrolled trial. J Pediatr 2003;143:725-30.
24. Schuh S, Coates AL, Binnic R. Efficacy of oral dexametasone in outpatients with acute bronchiolitis. J Pediatr 2002;140:27.
25. McBride JT. Dexametasone and bronchiolitis: a new look at an old therapy? J Pediatr 2002;140:8-12.
26. Cade A, Brownhee KG, Conway SP. Randomized placebo controled trial of nebulized corticosteroids in acute syncitial viral bronchiolitis. Arch Dis Child 2000;82:126.
27. Grenville F, Foxeverard ML, Marsh MJ, Millner AD. Randomized controled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child 1999;80:343.
28. Blom D, Emers M, Bont L, van Aalderen W, van Woensel J. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007;24:CD004881.
29. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Arch Pediatr Adolesc Med 1996;150:1166-72.
30. Spurling G, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2007;(1):CD 005189.
31. Wohl ME, Chernick V. Treatment of acute bronchiolitis. N Engl J Med 2003;349:82-3.
32. Breese Hall CC. Managing bronchiolitis and respiratory syncytial virus. Acta Paediatr Adolesc Med 2004;158:111.
33. Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis. A systematic review. Arch Pediatr Adolesc Med 2004;158:119-26.
34. van Woensel JB, van Aalderen WM. Treatment of bronchiolitis: the story continues. Lancet 2002;360:101-2.
35. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 1999;104:1334-41.
36. King WJ, Le Saux N, Sampson M, Gaboury I, Norris M, Moher D. Effect of point of care information on impatient management of bronchiolitis. BMC Pediatr 2007;7:4.
37. Hammerschlag MR. Clamidial infections. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Paediatrics. 17° ed. Philadelphia: WB Saunders, 2004:994-9.